Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 562

1.

Transcatheter Aortic Valve Replacement in Patients With Morbid Obesity: Procedure Outcomes and Medium-Term Follow-Up.

González Ferreiro R, López Otero D, Álvarez Rodríguez L, Iglesias Álvarez D, Cid Menéndez A, Antúnez Muiños PJ, Cid Álvarez B, Sanmartín Pena XC, Cruz-González I, Trillo Nouche R, González Juanatey JR.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1192-1193. doi: 10.1016/j.jcin.2019.04.012. No abstract available.

PMID:
31221309
2.

Obesity-Related Genetic Determinants of Heart Failure Prognosis.

Agra RM, Gago-Dominguez M, Paradela-Dobarro B, Torres-Español M, Alvarez L, Fernandez-Trasancos A, Varela-Roman A, Calaza M, Eiras S, Alvarez E, Carracedo A, Gonzalez-Juanatey JR.

Cardiovasc Drugs Ther. 2019 Jun 17. doi: 10.1007/s10557-019-06888-8. [Epub ahead of print]

PMID:
31209632
3.

Corrigendum to: A community intervention study on patients' resuscitation and defibrillation quality after embedded training in a cardiac rehabilitation program.

González-Salvado V, Abelairas-Gómez C, Peña-Gil C, Neiro-Rey C, Barcala-Furelos R, González-Juanatey JR, Rodríguez-Núñez A.

Health Educ Res. 2019 Jun 3. pii: cyz020. doi: 10.1093/her/cyz020. [Epub ahead of print] No abstract available.

PMID:
31157382
4.

Early revascularization and long-term mortality in high-risk patients with non-ST-elevation myocardial infarction. The CARDIOCHUS-HUSJ registry.

Álvarez Álvarez B, Abou Jokh Casas C, Cordero A, Martínez Gómez Á, Cid Álvarez AB, Agra Bermejo R, García Acuña JM, Gude Sampedro F, González Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 May 20. pii: S1885-5857(19)30078-7. doi: 10.1016/j.rec.2019.02.015. [Epub ahead of print] English, Spanish.

PMID:
31122784
5.

Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.

Raposeiras-Roubín S, Abu-Assi E, Cespón-Fernández M, Ibáñez B, García-Ruiz JM, D'Ascenzo F, Simao Henriques JP, Saucedo J, Caneiro-Queija B, Cobas-Paz R, Muñoz-Pousa I, Wilton SB, González Juanatey JR, Kikkert WJ, Núñez-Gil I, Ariza-Solé A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Gaita F, Huczek Z, Nie SP, Yan Y, Fujii T, Correia L, Kawashiri MA, Kedev S, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Kowara M, Filipiak K, Wang X, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 May 16. pii: S1885-5857(19)30054-4. doi: 10.1016/j.rec.2019.02.012. [Epub ahead of print] English, Spanish.

PMID:
31105064
6.

Initial real-world experience with PCSK-9 inhibitors in current indications for reimbursement in Spain.

Cordero A, Fácila L, Rodríguez-Mañero M, Gómez-Martínez MJ, Bertomeu-Martínez V, González-Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 May 15. pii: S1885-5857(19)30103-3. doi: 10.1016/j.rec.2019.03.008. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31103377
7.

The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy.

Gil-Cayuela C, López A, Martínez-Dolz L, González-Juanatey JR, Lago F, Roselló-Lletí E, Rivera M, Portolés M.

PLoS One. 2019 Apr 22;14(4):e0215818. doi: 10.1371/journal.pone.0215818. eCollection 2019.

8.

Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation.

Lopez-Canoa JN, Baluja A, Couselo-Seijas M, Naveira AB, Gonzalez-Melchor L, Rozados A, Martínez-Sande L, García-Seara J, Fernandez-Lopez XA, Fernandez AL, Gonzalez-Juanatey JR, Eiras S, Rodriguez-Mañero M.

Int J Cardiol. 2019 Apr 10. pii: S0167-5273(19)30422-X. doi: 10.1016/j.ijcard.2019.04.031. [Epub ahead of print]

PMID:
31005413
9.

Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors.

Cordero A, Fácila L, Galve E, González Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):518-519. doi: 10.1016/j.rec.2018.11.018. Epub 2019 Apr 10. English, Spanish. No abstract available.

PMID:
30981589
10.

Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.

Aragón-Herrera A, Feijóo-Bandín S, Abella V, Álvarez L, Roselló-Lletí E, Portolés M, Tarazón E, Bigazzi M, Bani D, Gualillo O, González-Juanatey JR, Lago F.

Pharmacol Res. 2019 Jun;144:51-65. doi: 10.1016/j.phrs.2019.04.009. Epub 2019 Apr 5.

PMID:
30954631
11.

Cardiac rehabilitation in the elderly patient in eight rehabilitation units in Western Europe: Baseline data from the EU-CaRE multicentre observational study.

Prescott E, Mikkelsen N, Holdgaard A, Eser P, Marcin T, Wilhelm M, Gil CP, González-Juanatey JR, Moatemri F, Iliou MC, Schneider S, Schromm E, Zeymer U, Meindersma EP, Ardissino D, Kolkman EK, Prins LF, van der Velde AE, Van 't Hof AW, de Kluiver EP.

Eur J Prev Cardiol. 2019 Jul;26(10):1052-1063. doi: 10.1177/2047487319839819. Epub 2019 Mar 29.

PMID:
30924688
12.

Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction.

Vicent L, Cinca J, Vazquez-García R, Gonzalez-Juanatey JR, Rivera M, Segovia J, Pascual-Figal D, Bover R, Worner F, Delgado-Jiménez J, Fernández-Avilés F, Martínez-Sellés M.

Intern Med J. 2019 Mar 19. doi: 10.1111/imj.14289. [Epub ahead of print]

PMID:
30887642
13.

Inflammatory effects of in vivo glycated albumin from cardiovascular patients.

Paradela-Dobarro B, Bravo SB, Rozados-Luís A, González-Peteiro M, Varela-Román A, González-Juanatey JR, García-Seara J, Alvarez E.

Biomed Pharmacother. 2019 May;113:108763. doi: 10.1016/j.biopha.2019.108763. Epub 2019 Mar 13.

14.

A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.

Rodríguez-Mañero M, López-Pardo E, Cordero A, Ruano-Ravina A, Novo-Platas J, Pereira-Vázquez M, Martínez-Gómez Á, García-Seara J, Martínez-Sande JL, Peña-Gil C, Mazón P, García-Acuña JM, Valdés-Cuadrado L, González-Juanatey JR.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 12;14:371-380. doi: 10.2147/COPD.S174443. eCollection 2019.

15.

Training Adult Laypeople in Basic Life Support. A Systematic Review.

González-Salvado V, Rodríguez-Ruiz E, Abelairas-Gómez C, Ruano-Raviña A, Peña-Gil C, González-Juanatey JR, Rodríguez-Núñez A.

Rev Esp Cardiol (Engl Ed). 2019 Feb 23. pii: S1885-5857(18)30492-4. doi: 10.1016/j.rec.2018.11.013. [Epub ahead of print] English, Spanish.

PMID:
30808611
16.

Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature.

Rodríguez-Mañero M, Kreidieh B, Valderrábano M, Baluja A, Martínez-Sande JL, García-Seara J, Díaz-Fernández B, Pereira-Vázquez M, Lage R, González-Melchor L, Fernández-López XA, González-Juanatey JR.

J Arrhythm. 2018 Sep 3;35(1):18-24. doi: 10.1002/joa3.12113. eCollection 2019 Feb. Review.

17.

Omentin protects H9c2 cells against docetaxel cardiotoxicity.

Lage R, Cebro-Márquez M, Rodríguez-Mañero M, González-Juanatey JR, Moscoso I.

PLoS One. 2019 Feb 22;14(2):e0212782. doi: 10.1371/journal.pone.0212782. eCollection 2019.

18.

Targeting relatives: Impact of a cardiac rehabilitation programme including basic life support training on their skills and attitudes.

González-Salvado V, Abelairas-Gómez C, Gude F, Peña-Gil C, Neiro-Rey C, González-Juanatey JR, Rodríguez-Núñez A.

Eur J Prev Cardiol. 2019 May;26(8):795-805. doi: 10.1177/2047487319830190. Epub 2019 Feb 19.

PMID:
30776898
19.

Cardiovascular Diseases: A Challenge for the New Era.

Borrayo-Sánchez G, González-Juanatey JR.

Arch Med Res. 2018 Nov;49(8):515. doi: 10.1016/j.arcmed.2019.01.003. Epub 2019 Feb 2. No abstract available.

PMID:
30718150
20.

Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system.

Rodríguez-Mañero M, López-Pardo E, Cordero-Fort A, Martínez-Sande JL, Peña-Gil C, Platas JN, García-Seara J, Mazón P, Varela-Román A, García-Acuña JM, González-Juanatey JR.

Rev Port Cardiol. 2019 Jan;38(1):21-29. doi: 10.1016/j.repc.2018.06.008. Epub 2019 Jan 15. English, Portuguese.

Supplemental Content

Loading ...
Support Center